Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies

Table 5 Factors affecting eradication of Helicobacter pylori n (%)

Factors	Eradicated	Not	Crude OR(95%CI)	P valuea	Adjust OR(95%CI)	P value1
Age	56.8 ± 12.9	57.6 ± 11.9	0.996	0.632
			(0.978-1.014)
Gender
Male	294	34	-	-	-	-
	(61.25)	(39.53)
Female	186	52	0.414	0.080
	(38.75)	(60.47)	(0.259-0.662)
Diagnosis
Gastric ulcer	225	38	1.121	0.663
	(46.88)	(44.19)	(0.673-1.869)
Duodenal ulcer	86	16	1.018	0.896
	(17.92)	(18.60)	(0.529-1.957)
Gastritis	169	32	-	-
	(35.21)	(37.21)
Treatment Group
PAC	109	34	-	-	-	-
	(22.71)	(39.53)
PAM	117	22	1.659	0.430	1.738	0.559
	(24.38)	(25.58)	(0.914-3.012)		(0.948-3.187)
Sequential	119	22	1.687	0.478	1.636	0.386
	(24.79)	(25.58)	(0.930-3.062)		(0.894-2.997)
Concomitant	135	8	5.264	0.001	5.287	0.001
	(28.13)	(9.3)	(2.341-11.838)		(2.335-11.973)
Alcohol Intake
Yes	165	27	1.145	0.591
	(34.38)	(31.4)	(0.699-1.874)
No	315	59	-	-
	(65.63)	(68.6)
Smoking
Smoker	127	18	1.359	0.281
	(26.46)	(20.93)	(0.778-2.374)
Non-smoker	353	68	-	-
	(73.54)	(79.07)
BMI	22.7 ± 2.7	22.2 ± 2.9	1.073	0.107
			(0.985-1.169)
Total Cholesterol	188.2 ± 39.9	188.8 ± 35.1	1.000	0.914
			(0.993-1.007)
LDL Cholesterol	107.3 ± 32.5	109.8 ± 31.8	0.998	0.601
			(0.989-1.007)

¹P-value of Wald test for coefficients of logistic regression. PAC: Rabeprazole, amoxicillin, clarithromycin; PAM: Rabeprazole, amoxicillin, metronidazole; BMI: Body mass index; LDL: Low density lipoprotein.